Laurent Pharmaceuticals

company

About

Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical-stage, orally-active drug candidate. The company has a clinical-stage drug development program (LAU-7b) that addresses the compromised immune-inflammatory response in Cystic Fibrosis (CF), a critical but still enigmatic pathogenic pathway leading to pulmonary insufficiency in CF patients.

Laurent Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Laurent Pharmaceuticals has raised a total of — in funding over 2 rounds. Their latest funding was raised on Oct 25, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 25, 2018 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Laurent Pharmaceuticals is funded by 1 investors. Keiretsu Forum Mid Atlantic are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Mid Atlantic Series Unknown